Australia targets reduced drug spending with new reforms
27-05-2015
‘Worrying trend’ of Aussie counterfeit pharmaceuticals
09-10-2014
04-05-2016
Christophe BOISSON / Shutterstock.com
Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Commissioner, patent, pharmaceutical, Productivity Commission, Jonathan Coppel, report,